• Tomoyasu Tsushima, Takafumi Miura, Takahiko Hachiya, Ichiro Nakamura, Toyoko Yamato, Takeshi Kishida, Yoshinori Tanaka, Shin Irie, Norio Meguro, Takashi Kawahara, and Nobuhisa Nakajima.
• 1 Department of Urology, National Hospital Organization Okayama Medical Center , Okayama, Japan .
• J Palliat Med. 2019 Jan 1; 22 (1): 54-61.

BackgroundUrological symptoms such as gross hematuria, lower and upper urinary tract symptoms, and bladder pain are common in and distressing for patients with advanced cancer. Although palliation of urological symptoms is important to improve the quality of life of cancer patients and their families and caregivers, clinical guidelines for managing urological symptoms in patients with cancer have not been published.MethodsFollowing the formal guideline development process, the Japanese Society for Palliative Medicine (JSPM) developed comprehensive clinical guidelines for the management of urological symptoms in patients with cancer.ResultsThis article summarizes the recommendations and their rationales and provides a short summary of the development process of the JSPM urological symptom management guidelines. We established five recommendations, all of which were based on the best available evidence and expert consensus.ConclusionJSPM released the first edition of the "Clinical Guidelines for Urological Symptoms in Cancer Patients." Future clinical research and continuous guideline updates are required to improve the quality of managing urological symptoms in patients with cancer.

22 keywords...

hide…